Burns Blaxall
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Heart Failure | 11 | 1996 | 106 |
Why?
| Myocytes, Cardiac | 17 | 2005 | 40 |
Why?
| Myocardium | 11 | 1996 | 119 |
Why?
| RNA-Binding Proteins | 6 | 1996 | 55 |
Why?
| Heart | 4 | 2000 | 88 |
Why?
| Cytoskeletal Proteins | 2 | 2010 | 55 |
Why?
| Cardiovascular Diseases | 2 | 2010 | 127 |
Why?
| Antigens, Surface | 3 | 2000 | 51 |
Why?
| Mice | 23 | 2000 | 623 |
Why?
| Signal Transduction | 8 | 1996 | 313 |
Why?
| Ventricular Remodeling | 3 | 2007 | 21 |
Why?
| RNA, Messenger | 9 | 1996 | 394 |
Why?
| Gene Expression Profiling | 5 | 2003 | 138 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein D | 3 | 1996 | 3 |
Why?
| Receptors, Adrenergic, beta | 6 | 1996 | 35 |
Why?
| RNA Stability | 3 | 2000 | 38 |
Why?
| G-Protein-Coupled Receptor Kinases | 1 | 2011 | 2 |
Why?
| S100 Proteins | 1 | 2011 | 19 |
Why?
| Protein Kinase Inhibitors | 2 | 2008 | 59 |
Why?
| Animals | 34 | 1994 | 1032 |
Why?
| Mechanoreceptors | 1 | 2010 | 9 |
Why?
| Gene Expression Regulation | 4 | 1996 | 279 |
Why?
| Therapies, Investigational | 1 | 2010 | 3 |
Why?
| Echocardiography, Doppler, Color | 1 | 2010 | 8 |
Why?
| Translational Medical Research | 1 | 2010 | 20 |
Why?
| Microfilament Proteins | 1 | 2011 | 41 |
Why?
| Heart-Assist Devices | 3 | 2003 | 16 |
Why?
| GTP-Binding Protein beta Subunits | 1 | 2010 | 10 |
Why?
| GTP-Binding Protein gamma Subunits | 1 | 2010 | 10 |
Why?
| Cardiomegaly | 5 | 2005 | 36 |
Why?
| Gene Therapy | 1 | 2011 | 89 |
Why?
| Myocardial Contraction | 5 | 2005 | 52 |
Why?
| Myelin Proteins | 1 | 2007 | 8 |
Why?
| Angiotensin II | 5 | 2005 | 31 |
Why?
| Cardiac Output, Low | 2 | 2003 | 9 |
Why?
| Muscle Proteins | 2 | 2005 | 56 |
Why?
| Carrier Proteins | 1 | 2010 | 177 |
Why?
| Heart Diseases | 1 | 2007 | 92 |
Why?
| Heart Ventricles | 4 | 2003 | 86 |
Why?
| Receptors, Mineralocorticoid | 1 | 2005 | 8 |
Why?
| Ventricular Dysfunction, Left | 2 | 2003 | 35 |
Why?
| Mutation | 1 | 2010 | 340 |
Why?
| Humans | 27 | 1996 | 1858 |
Why?
| Calcium Signaling | 5 | 2006 | 52 |
Why?
| Disease Models, Animal | 6 | 2003 | 349 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2003 | 135 |
Why?
| 3' Untranslated Regions | 2 | 1998 | 21 |
Why?
| Mice, Knockout | 7 | 2005 | 265 |
Why?
| beta-Adrenergic Receptor Kinases | 3 | 2003 | 8 |
Why?
| Globins | 1 | 2002 | 21 |
Why?
| 3',5'-Cyclic-AMP Phosphodiesterases | 3 | 2005 | 8 |
Why?
| Gene Expression | 3 | 2000 | 291 |
Why?
| Cardiomyopathy, Dilated | 3 | 2007 | 24 |
Why?
| Calcium | 6 | 2005 | 210 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2000 | 7 |
Why?
| Receptors, Adrenergic | 1 | 2000 | 17 |
Why?
| Guanine Nucleotide Exchange Factors | 3 | 2006 | 14 |
Why?
| LIM Domain Proteins | 2 | 2007 | 12 |
Why?
| Mice, Inbred C57BL | 5 | 2005 | 318 |
Why?
| Muscle, Smooth, Vascular | 3 | 2005 | 59 |
Why?
| Chemokine CCL2 | 2 | 2007 | 57 |
Why?
| Myocardial Reperfusion Injury | 2 | 2006 | 29 |
Why?
| Thromboplastin | 3 | 2005 | 21 |
Why?
| Receptor, Angiotensin, Type 1 | 2 | 2005 | 7 |
Why?
| Apoptosis | 5 | 2000 | 265 |
Why?
| Mice, Transgenic | 6 | 2000 | 209 |
Why?
| Hypertension, Pulmonary | 2 | 2005 | 22 |
Why?
| Lung Neoplasms | 1 | 2000 | 160 |
Why?
| Cyclic AMP Response Element Modulator | 2 | 2005 | 7 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2006 | 6 |
Why?
| Male | 15 | 2000 | 1558 |
Why?
| Type C Phospholipases | 2 | 2005 | 34 |
Why?
| Rats | 12 | 2005 | 532 |
Why?
| Disease Progression | 2 | 2003 | 244 |
Why?
| Blotting, Northern | 3 | 2003 | 152 |
Why?
| Isoproterenol | 7 | 1998 | 47 |
Why?
| Phosphoinositide Phospholipase C | 3 | 2005 | 9 |
Why?
| Rats, Sprague-Dawley | 7 | 2005 | 257 |
Why?
| Phosphorylation | 3 | 2006 | 224 |
Why?
| Recombinant Proteins | 4 | 1996 | 290 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2007 | 17 |
Why?
| Apolipoproteins E | 1 | 2011 | 26 |
Why?
| Connexin 43 | 1 | 2011 | 14 |
Why?
| Receptor, PAR-2 | 1 | 2010 | 6 |
Why?
| Xanthenes | 1 | 2010 | 8 |
Why?
| Cyclophilin A | 1 | 2011 | 11 |
Why?
| HL-60 Cells | 1 | 2010 | 28 |
Why?
| Diffusion of Innovation | 1 | 2010 | 23 |
Why?
| Immunohistochemistry | 2 | 2000 | 356 |
Why?
| Protein Kinase C-delta | 1 | 2010 | 10 |
Why?
| Cyclohexanes | 1 | 2010 | 15 |
Why?
| Gap Junctions | 1 | 2011 | 15 |
Why?
| Feedback, Physiological | 2 | 2005 | 26 |
Why?
| Receptors, Adrenergic, beta-1 | 2 | 1998 | 2 |
Why?
| Cricetinae | 2 | 2000 | 130 |
Why?
| Second Messenger Systems | 1 | 2009 | 19 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2009 | 9 |
Why?
| Xenopus | 1 | 2010 | 37 |
Why?
| Calmodulin | 1 | 2009 | 34 |
Why?
| Receptor, Serotonin, 5-HT2B | 1 | 2008 | 3 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2008 | 13 |
Why?
| Fibroblasts | 2 | 2008 | 179 |
Why?
| Receptor, PAR-1 | 1 | 2007 | 10 |
Why?
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2008 | 13 |
Why?
| Protein Binding | 2 | 2000 | 256 |
Why?
| Transcriptional Activation | 2 | 2005 | 99 |
Why?
| Base Sequence | 3 | 1996 | 371 |
Why?
| Reactive Oxygen Species | 2 | 2005 | 112 |
Why?
| Receptors, Glucocorticoid | 1 | 2007 | 26 |
Why?
| Receptors, CXCR4 | 1 | 2006 | 18 |
Why?
| Pulmonary Artery | 1 | 2007 | 58 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 62 |
Why?
| Gene Deletion | 1 | 2007 | 121 |
Why?
| Mitogen-Activated Protein Kinase 7 | 1 | 2007 | 10 |
Why?
| Kallikreins | 1 | 2006 | 6 |
Why?
| Receptors, Endothelin | 1 | 2006 | 15 |
Why?
| Recovery of Function | 1 | 2007 | 91 |
Why?
| Sodium-Hydrogen Antiporter | 1 | 2006 | 18 |
Why?
| RNA, Nuclear | 1 | 2005 | 3 |
Why?
| Diabetic Angiopathies | 1 | 2006 | 24 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2006 | 36 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2005 | 5 |
Why?
| Aldosterone | 1 | 2005 | 14 |
Why?
| Cyclic AMP | 4 | 2005 | 90 |
Why?
| Trinucleotide Repeat Expansion | 1 | 2005 | 21 |
Why?
| Cells, Cultured | 5 | 2006 | 447 |
Why?
| Antihypertensive Agents | 1 | 2006 | 55 |
Why?
| Lymphocytes | 1 | 2006 | 142 |
Why?
| Myocardial Ischemia | 1 | 2006 | 62 |
Why?
| Myocytes, Smooth Muscle | 1 | 2007 | 35 |
Why?
| Half-Life | 2 | 1998 | 69 |
Why?
| Myotonic Dystrophy | 1 | 2005 | 21 |
Why?
| Genome, Human | 1 | 2003 | 29 |
Why?
| Sarcoplasmic Reticulum | 3 | 2005 | 21 |
Why?
| Ultraviolet Rays | 2 | 1996 | 76 |
Why?
| Hypertension | 1 | 2006 | 161 |
Why?
| Cardiac Surgical Procedures | 1 | 2003 | 35 |
Why?
| Regulatory Sequences, Ribonucleic Acid | 1 | 2002 | 1 |
Why?
| Myocardial Infarction | 1 | 2007 | 129 |
Why?
| Base Composition | 1 | 2002 | 20 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 3 | 2005 | 6 |
Why?
| Uracil | 1 | 2002 | 18 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 45 |
Why?
| Cell Nucleus | 1 | 2005 | 169 |
Why?
| Regression Analysis | 1 | 2003 | 256 |
Why?
| Adenine | 1 | 2002 | 26 |
Why?
| Middle Aged | 5 | 2003 | 1166 |
Why?
| Inflammation | 3 | 2007 | 208 |
Why?
| Transfection | 2 | 1998 | 237 |
Why?
| Female | 4 | 2000 | 1646 |
Why?
| Enzyme Inhibitors | 3 | 2005 | 216 |
Why?
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2000 | 8 |
Why?
| Time Factors | 2 | 2002 | 896 |
Why?
| Chromatography, Affinity | 1 | 2000 | 49 |
Why?
| Precipitin Tests | 1 | 2000 | 81 |
Why?
| Mass Spectrometry | 1 | 2000 | 57 |
Why?
| Ribonucleoproteins | 1 | 2000 | 21 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 71 |
Why?
| Aging | 1 | 2005 | 275 |
Why?
| Mice, Inbred BALB C | 1 | 2000 | 176 |
Why?
| Calcium Channels, L-Type | 2 | 2008 | 15 |
Why?
| Ryanodine Receptor Calcium Release Channel | 2 | 2008 | 21 |
Why?
| Tumor Cells, Cultured | 1 | 2000 | 233 |
Why?
| Oxidative Stress | 2 | 2010 | 119 |
Why?
| Molecular Sequence Data | 2 | 1996 | 404 |
Why?
| Blotting, Western | 2 | 2008 | 275 |
Why?
| Amino Acid Sequence | 1 | 2000 | 319 |
Why?
| Transduction, Genetic | 2 | 2006 | 66 |
Why?
| Enzyme Activation | 2 | 2007 | 177 |
Why?
| Cell Proliferation | 2 | 2007 | 227 |
Why?
| Lysophosphatidylcholines | 1 | 1994 | 25 |
Why?
| Adrenergic beta-Agonists | 2 | 1998 | 39 |
Why?
| Blood Pressure | 2 | 2005 | 205 |
Why?
| Phospholipases A | 1 | 1994 | 24 |
Why?
| Echocardiography | 2 | 2000 | 93 |
Why?
| Cell Communication | 1 | 2011 | 72 |
Why?
| Bone Marrow Cells | 1 | 2011 | 92 |
Why?
| Adult | 3 | 2006 | 1321 |
Why?
| Cyclic GMP | 1 | 2009 | 30 |
Why?
| Cardiotonic Agents | 1 | 2009 | 21 |
Why?
| Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 1 |
Why?
| Protein Kinase C-epsilon | 1 | 2008 | 9 |
Why?
| Benzylamines | 1 | 2008 | 9 |
Why?
| Serotonin Antagonists | 1 | 2008 | 9 |
Why?
| Animals, Newborn | 1 | 2011 | 175 |
Why?
| Protein Interaction Mapping | 1 | 2008 | 19 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2008 | 15 |
Why?
| Bone Marrow Transplantation | 1 | 2011 | 90 |
Why?
| src-Family Kinases | 1 | 2008 | 30 |
Why?
| Cell Movement | 1 | 2011 | 163 |
Why?
| Adenoviridae Infections | 1 | 2008 | 9 |
Why?
| Calcium-Binding Proteins | 1 | 2008 | 49 |
Why?
| Ventricular Myosins | 1 | 2007 | 3 |
Why?
| Actin Cytoskeleton | 1 | 2008 | 14 |
Why?
| Animals, Genetically Modified | 1 | 2008 | 29 |
Why?
| Norepinephrine | 1 | 2008 | 68 |
Why?
| Receptor, Epidermal Growth Factor | 1 | 2008 | 54 |
Why?
| Protein Transport | 1 | 2008 | 101 |
Why?
| Sulfonamides | 1 | 2008 | 74 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 104 |
Why?
| Monocrotaline | 1 | 2007 | 3 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 64 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2007 | 4 |
Why?
| Mice, Mutant Strains | 1 | 2007 | 77 |
Why?
| Pneumonectomy | 1 | 2007 | 15 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 243 |
Why?
| rap GTP-Binding Proteins | 1 | 2006 | 4 |
Why?
| Cell-Free System | 1 | 2007 | 35 |
Why?
| von Willebrand Factor | 1 | 2007 | 34 |
Why?
| Cytochromes c | 1 | 2008 | 29 |
Why?
| Reperfusion Injury | 1 | 2007 | 22 |
Why?
| Electric Stimulation | 1 | 2007 | 101 |
Why?
| Angiography | 1 | 2007 | 63 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 18 |
Why?
| Papillary Muscles | 1 | 2006 | 14 |
Why?
| Cell Separation | 1 | 2008 | 110 |
Why?
| Evoked Potentials | 1 | 2006 | 45 |
Why?
| Chemokine CXCL12 | 1 | 2006 | 24 |
Why?
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2006 | 6 |
Why?
| Chemokines, CXC | 1 | 2006 | 32 |
Why?
| Atherosclerosis | 1 | 2007 | 29 |
Why?
| Hormone Antagonists | 1 | 2007 | 26 |
Why?
| Drug Synergism | 1 | 2006 | 104 |
Why?
| Myocardial Reperfusion | 1 | 2006 | 17 |
Why?
| Mifepristone | 1 | 2007 | 30 |
Why?
| Cation Transport Proteins | 1 | 2006 | 17 |
Why?
| Doxorubicin | 1 | 2007 | 60 |
Why?
| Renin-Angiotensin System | 1 | 2006 | 15 |
Why?
| Cell Membrane | 1 | 2008 | 170 |
Why?
| Vasoconstriction | 1 | 2006 | 37 |
Why?
| Adenoviridae | 1 | 2006 | 60 |
Why?
| Cardiomyopathies | 1 | 2006 | 43 |
Why?
| Aged | 2 | 2006 | 992 |
Why?
| Dexamethasone | 1 | 2007 | 109 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 80 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2005 | 5 |
Why?
| Luciferases | 1 | 2005 | 70 |
Why?
| Genomics | 1 | 2005 | 36 |
Why?
| Conserved Sequence | 1 | 2005 | 73 |
Why?
| Alternative Splicing | 1 | 2005 | 51 |
Why?
| Sodium Channels | 1 | 2005 | 32 |
Why?
| Hemodynamics | 1 | 2006 | 131 |
Why?
| Calcium Channels | 1 | 2006 | 52 |
Why?
| Tunica Intima | 1 | 2005 | 31 |
Why?
| Phenotype | 1 | 2007 | 304 |
Why?
| Cytokines | 1 | 2008 | 207 |
Why?
| Genetic Vectors | 1 | 2006 | 139 |
Why?
| Endothelial Cells | 1 | 2007 | 80 |
Why?
| Heart Rate | 1 | 2005 | 138 |
Why?
| Protein-Serine-Threonine Kinases | 1 | 2005 | 105 |
Why?
| Case-Control Studies | 1 | 2005 | 284 |
Why?
| Promoter Regions, Genetic | 1 | 2005 | 188 |
Why?
| Membrane Proteins | 1 | 2006 | 233 |
Why?
| bcl-2-Associated X Protein | 1 | 2000 | 40 |
Why?
| Drug Stability | 1 | 1998 | 32 |
Why?
| Protein Synthesis Inhibitors | 1 | 1998 | 33 |
Why?
| Cycloheximide | 1 | 1998 | 51 |
Why?
| Treatment Outcome | 1 | 2006 | 662 |
Why?
| Proto-Oncogene Proteins | 1 | 2000 | 113 |
Why?
| Biological Markers | 1 | 2000 | 263 |
Why?
| Protein Biosynthesis | 1 | 1998 | 113 |
Why?
| Polyribosomes | 1 | 1996 | 15 |
Why?
| Muscle, Smooth | 1 | 1996 | 69 |
Why?
| GTP-Binding Proteins | 1 | 1996 | 47 |
Why?
| Agkistrodon | 1 | 1994 | 1 |
Why?
| Crotalid Venoms | 1 | 1994 | 2 |
Why?
| DNA Primers | 1 | 1996 | 208 |
Why?
| Phospholipases A2 | 1 | 1994 | 16 |
Why?
| Tryptophan | 1 | 1994 | 21 |
Why?
| Cell Line | 1 | 1998 | 375 |
Why?
| Spectrometry, Fluorescence | 1 | 1994 | 59 |
Why?
| Kinetics | 1 | 1994 | 349 |
Why?
|
|
Blaxall's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
